The global orthopedic cartilage repair market was valued at $405 million in 2024 and is expected to grow at a CAGR of 9.2%, reaching $750 million by 2031.
This market includes four key product categories:
- Osteochondral Allografts
- Meniscal Allografts
- Autologous Chondrocyte Implantation (ACI)
- Osteochondral Autografts
Market Insights & Data Coverage
- Unit Sales & Average Selling Prices
- Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031
- Historical Data (2021-2023)
- Competitive Landscape, Mergers & Acquisitions
- Company Profiles & Product Portfolios
Market Trends & Challenges
- High Cost as a Key Market Limiter
- The high cost of procedures remains a significant barrier for patients, even for those with private insurance.
- This cost is not expected to decline significantly over the forecast period, limiting unit sales.
- Technological Advancements Driving Growth
- The FDA’s approval of arthroscopic delivery methods for cartilage repair in 2024 enhances minimally invasive procedures and faster recovery times.
Market Share Insights
Top Competitors in the Global Orthopedic Cartilage Repair Market (2024):1 Vericel - Market Leader
- Offers MACI®, an autologous cartilage repair therapy for knee defects.
- The FDA-approved arthroscopic delivery method (August 2024) enables less invasive procedures.
2 Octane Medical Group - Second-Largest Competitor
- Expanded its portfolio by acquiring B. Braun’s global orthobiologics business (TETEC AG, Aesculap Biologics).
- Offers NOVOCART® 3D (matrix-associated ACI system) and NOVOCART® Inject (injectable hydrogel-based cartilage repair).
3 Arthrex - Third-Largest Competitor
- Provides Allograft OATS®, Autograft OATS®, BioCartilage®, and Cartiform® for osteochondral defect repair.
- The PowerPick system enables microdrilling for microfracture procedures.
Market Segmentation Summary
- Osteochondral Allograft Market
- Meniscal Allograft Market
- Autologous Chondrocyte Implantation (ACI) Market
- Osteochondral Autograft Market
Global Research Scope
- Regions Covered:
- North America (U.S., Canada)
- Latin America (Brazil, Mexico, Argentina, Colombia, Chile)
- Western Europe (Germany, France, U.K., Spain, Italy)
- Central & Eastern Europe (Poland, Russia, Turkey, Hungary)
- Middle East (Saudi Arabia, UAE, Israel)
- Asia Pacific (China, Japan, India, South Korea, Australia)
- Africa (South Africa, Egypt, Nigeria, Kenya)
- Base Year: 2024
- Forecast Period: 2025-2031
- Historical Data: 2021-2023
Quantitative Coverage
- Market Size, Market Shares
- Market Forecasts, Growth Rates
- Units Sold, Average Selling Prices
- Procedure Numbers
Qualitative Coverage
- COVID-19 Impact
- Market Growth Trends & Limiters
- Competitive Analysis & SWOT for Top Competitors
- Mergers & Acquisitions
- Company Profiles & Product Portfolios
- FDA Recalls, Disruptive Technologies
- Disease Overviews
Data Sources:
- Primary Interviews with Industry Leaders
- Government Physician Data & Regulatory Data
- Hospital Private Data
- Import & Export Data
- Internal Database
Table of Contents
- Executive Summary
- Global Orthopedic Cartilage Repair Market Overview
- Regions Included
- Introduction
- Anatomy
- Methods for Cartilage Repair
- Osteochondral Allograft Transfer
- Autologous Chondrocyte Implantation
- Meniscal Allograft Transplantation
- Osteochondral Autograft
- Microfracture
- Microfracture Adjunct
- Osteoarticular Autograft Transfer System
- Particulated Juvenile Allograft
- Procedure Numbers
- Total Orthopedic Cartilage Repair Procedures
- Osteochondral Allograft Procedures
- Meniscal Allograft Procedures
- Autologous Chondrocyte Implantation Procedures
- Osteochondral Autograft Procedures
- Market Overview
- By Segment
- By Region
- Market Analysis and Forecast
- Total Orthopedic Cartilage Repair Market
- Osteochondral Allograft Market
- Meniscal Allograft Market
- Autologous Chondrocyte Implantation Market
- Osteochondral Autograft Market
- Drivers and Limiters
- Market Drivers
- Market Limiters
- Competitive Market Share Analysis
- Orthopedic Cartilage Repair Market, Global, 2024 & 2031
- Orthopedic Cartilage Repair Procedures, Global, 2024
- Orthopedic Cartilage Repair Procedures by Segment, Global, 2021 - 2031
- Orthopedic Cartilage Repair Device Market by Segment, Global, 2021 - 2031
- Orthopedic Cartilage Repair Device Market by Region, Global, 2021 - 2031
- Leading Competitors, Cartilage Repair Market, Global, 2024
- Orthopedic Cartilage Repair Regions Covered, Global
- Orthopedic Cartilage Repair Procedures by Segment, Global, 2021 - 2031
- Orthopedic Cartilage Repair Procedures by Region, Global, 2021 - 2031
- Osteochondral Allograft Procedures by Region, Global, 2021 - 2031
- Meniscal Allograft Procedures by Region, Global, 2021 - 2031
- Autologous Chondrocyte Implantation Procedures by Region, Global, 2021 - 2031
- Osteochondral Autograft Procedures by Region, Global, 2021 - 2031
- Orthopedic Cartilage Repair Device Market by Segment, Global, 2021 - 2031 (US$M)
- Orthopedic Cartilage Repair Device Market by Region, Global, 2021 - 2031 (US$M)
- Orthopedic Cartilage Repair Market, Global, 2021 - 2031
- Units Sold by Region, Orthopedic Cartilage Repair Market, Global, 2021 - 2031
- Average Selling Price by Region, Orthopedic Cartilage Repair Market, Global, 2021 - 2031 (US$)
- Market Value by Region, Orthopedic Cartilage Repair Market, Global, 2021 - 2031 (US$M)
- Osteochondral Allograft Market, Global, 2021 - 2031
- Units Sold by Region, Osteochondral Allograft Market, Global, 2021 - 2031
- Average Selling Price by Region, Osteochondral Allograft Market, Global, 2021 - 2031 (US$)
- Market Value by Region, Osteochondral Allograft Market, Global, 2021 - 2031 (US$M)
- Meniscal Allograft Market, Global, 2021 - 2031
- Units Sold by Region, Meniscal Allograft Market, Global, 2021 - 2031
- Average Selling Price by Region, Meniscal Allograft Market, Global, 2021 - 2031 (US$)
- Market Value by Region, Meniscal Allograft Market, Global, 2021 - 2031 (US$M)
- Autologous Chondrocyte Implantation Market, Global, 2021- 2031
- Units Sold by Region, Autologous Chondrocyte Implantation Market, Global, 2021 - 2031
- Average Selling Price by Region, Autologous Chondrocyte Implantation Market, Global, 2021 - 2031 (US$)
- Market Value by Region, Autologous Chondrocyte Implantation Market, Global, 2021 - 2031 (US$M)
- Osteochondral Autograft Market, Global, 2021 - 2031
- Units Sold by Region, Osteochondral Autograft Market, Global, 2021 - 2031
- Average Selling Price by Region, Osteochondral Autograft Market, Global, 2021 - 2031 (US$)
- Market Value by Region, Osteochondral Autograft Market, Global, 2021 - 2031 (US$M)
- Leading Competitors, Cartilage Repair Market, Global, 2024
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie
- LCA Pharma
- Acumed
- LifeLink Tissue Bank
- AlloSource
- LifeNet Health
- Alphatec Spine
- Meda Pharma
- Anika Therapeutics
- Medtronic
- Arthrex
- MTF
- B. Braun Melsungen
- Novabone
- Baxter
- Nuo Therapeutics
- Berkeley Advanced Biomaterials
- Octane Medical
- Biocell
- Orthocell Ltd.
- Biocomposites
- OrthogenRx
- Biogennix
- Orthofix
- Bioiberica
- Osteogenics
- Biomatlante
- OsteoMed
- Biotissue Technologies
- Paragon 28
- Bioventus
- Plasmaconcept
- Bonalive
- PromoCell
- Celling Biosciences
- Rebone Biomaterials
- Cerapedics
- Recordati
- Cingal
- Regenexx
- Croma-Pharma
- Regenity Biosciences
- CO.DON GmbH
- RTI Surgical
- CONMED
- Sanofi
- Curasan
- Sartorius CellGenix GmbH
- DCI Donor Services
- Seikagaku
- DePuy Synthes
- Smith & Nephew
- Documedica
- Solvita
- Elutia Inc.
- Spinal Elements
- Exactech
- Stella Pharmaceuticals
- Ferring Pharmaceuticals
- Stryker
- Fidia
- Takara Bio
- Finceramica
- Tedec-Meiji
- Geistlich
- Terumo
- Globus Medical/NuVasive
- Teva Pharmaceutical
- Hanmi Pharmaceutical
- ThermoGenesis
- Healiva
- TRB Chemedica
- IBSA Pharma
- Viatris
- Integra LifeSciences
- Vericel
- Isto Biologics
- Vivex
- Kolon Tissuegene
- Xtant Medical
- Kuros
- Zimmer Biomet
